Pier Capital, LLC

Position in DXCM — Dexcom Inc

CIK 1310051 STAMFORD, CT

Position in DXCM

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$374,790

+$372,534 QoQ

Shares Held

5,968

+17452.9% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Pier Capital, LLC holds $21,292,114 across 6 Medical Devices names. DXCM ranks #6 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ESTA	Establishment Labs Holdings Inc.	133,567	$7,583,934
2	SIBN	SI-BONE, Inc.	476,805	$6,022,047
3	GKOS	GLAUKOS Corp	29,261	$3,150,239
4	ATEC	Alphatec Holdings, Inc.	223,159	$2,427,969
5	QTRX	Quanterix Corp	492,368	$1,733,135
6	DXCM	Dexcom Inc This page	5,968	$374,790

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$374,790	5,968	+17452.9%	Shares	Sole	2026-05-14
2025-12-31	$2,256	34	-66.7%	Shares	Sole	2026-02-03
2025-09-30	$6,863	102	+13.3%	Shares	Sole	2025-11-13
2025-06-30	$7,856	90	0.0%	Shares	Sole	2025-08-05
2025-03-31	$6,146	90	0.0%	Shares	Sole	2025-05-13
2024-12-31	$6,999	90	+66.7%	Shares	Sole	2025-02-11
2024-09-30	$3,620	54	0.0%	Shares	Sole	2024-11-15
2024-06-30	$6,122	54	-28.0%	Shares	Sole	2024-08-07
2024-03-31	$10,402	75	-98.8%	Shares	Sole	2024-05-03
2023-12-31	$794,176	6,400	+37.0%	Shares	Sole	2024-02-15
2023-09-30	$435,897	4,672	+1.6%	Shares	Sole	2023-11-14
2023-06-30	$591,146	4,600	-13.2%	Shares	Sole	2023-08-14
2023-03-31	$615,521	5,298	-14.9%	Shares	Sole	2023-05-10
2022-12-31	$704,805	6,224	+192.9%	Shares	Sole	2023-02-15
2020-03-31	$143,049	2,125	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.